Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1
New York, New York
This trial will evaluate a new therapy for relapsed/refractory B-cell lymphoma to see if it is safe and effective, and to determine the best dose to use.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service